Enzymatic cross-linking of collagens in organ fibrosis – resolution and assessment

References

• Hornstra IK, Birge S, Starcher B, et al. Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem. 2003;278(16):14387–14393.
   PubMed Web of Science ®Google Scholar
• Mäki JM, Sormunen R, Lippo S, et al. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am J Pathol. 2005;167(4):927–936.
   PubMed Web of Science ®Google Scholar
• Herchenhan A, Uhlenbrock F, Eliasson P, et al. Lysyl oxidase activity is required for ordered collagen fibrillogenesis by tendon cells. J Biol Chem. 2015;290(26):16440–16450.
   PubMed Web of Science ®Google Scholar
• Turecek C, Fratzl-Zelman N, Rumpler M, et al. Collagen cross-linking influences osteoblastic differentiation. Calcif Tissue Int. 2008;82(5):392–400.
   PubMed Web of Science ®Google Scholar
• Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg. 2005;31(6):674–686. discussion 686
   PubMed Web of Science ®Google Scholar
• Fushida-Takemura H, Fukuda M, Maekawa N, et al. Detection of lysyl oxidase gene expression in rat skin during wound healing. Arch Dermatol Res. 1996;288(1):7–10.
   PubMed Web of Science ®Google Scholar
• Nicholas B, Smethurst P, Verderio E, et al. Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity. Biochem J. 2003;371(2):413–422.
   PubMed Web of Science ®Google Scholar
• Haroon ZA, Hettasch JM, Lai TS, et al. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J. 1999;13(13):1787–1795.
   PubMed Web of Science ®Google Scholar
• Weiskirchen R, Weiskirchen S, Tacke F. Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications. Mol Aspects Med. 2019;65:2–15.
   PubMed Web of Science ®Google Scholar
• Eyre DR, Wu -J-J. Collagen cross-links, in: top. Curr Chem. 2005;207–229. DOI:https://doi.org/10.1007/b103828
   Google Scholar
• Añazco C, López-Jiménez AJ, Rafi M, et al. Lysyl oxidase-like-2 cross-links collagen IV of glomerular basement membrane. J Biol Chem. 2016;291(50):25999–26012.
   PubMed Web of Science ®Google Scholar
• Yamauchi M, Sricholpech M. Lysine post-translational modifications of collagen. Essays Biochem. 2012;52:113–133
   PubMed Web of Science ®Google Scholar
• Griffin M, Casadio R, Bergamini CM. Transglutaminases: nature’s biological glues. Biochem J. 2002;368(2):377–396.
   PubMed Web of Science ®Google Scholar
• Thomázy V, Fésüs L. Differential expression of tissue transglutaminase in human cells. An immunohistochemical study. Cell Tissue Res. 1989;255(1):215–224.
   PubMed Web of Science ®Google Scholar
• Belkin AM. Extracellular TG2: emerging functions and regulation. FEBS J. 2011;278(24):4704–4716.
   PubMed Web of Science ®Google Scholar
• Collighan RJ, Griffin M. Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids. 2009;36(4):659–670.
   PubMed Web of Science ®Google Scholar
• Péterfi Z, Geiszt M. Peroxidasins: novel players in tissue genesis. Trends Biochem Sci. 2014;39(7):305–307.
   PubMed Web of Science ®Google Scholar
• Péterfi Z, Donkó A, Orient A, et al. Peroxidasin is secreted and incorporated into the extracellular matrix of myofibroblasts and fibrotic kidney. Am J Pathol. 2009;175(2):725–735.
   PubMed Web of Science ®Google Scholar
• Sun Z, Guo SS, Fässler R. Integrin-mediated mechanotransduction. J Cell Biol. 2016;215:445–456.
   PubMed Web of Science ®Google Scholar
• Georges PC, Hui -J-J, Gombos Z, et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol. 2007;293(6):G1147–54.
   PubMed Web of Science ®Google Scholar
• Herrera J, Henke CA, Bitterman PB. Extracellular matrix as a driver of progressive fibrosis. J Clin Invest. 2018;128(1):45–53.
   PubMed Web of Science ®Google Scholar
• Parker MW, Rossi D, Peterson M, et al. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest. 2014;124(4):1622–1635.
   PubMed Web of Science ®Google Scholar
• Wynn TA. Fibrotic disease and the TH1/TH2 paradigm. Nat Rev Immunol. 2004;4(8):583–594.
   PubMed Web of Science ®Google Scholar
• Jensen C, Holm Nielsen S, Eslam M, et al. Cross-linked multimeric pro-peptides of type III collagen (PC3X) in hepatocellular carcinoma - a biomarker that provides additional prognostic value in AFP positive patients. J Hepatocell Carcinoma. 2020;7:301–313.
   PubMed Web of Science ®Google Scholar
• Rosenquist C, Fledelius C, Christgau S, et al. Serum CrossLaps one step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem. 1998;44(11):2281–2289. http://www.ncbi.nlm.nih.gov/pubmed/9799755
   PubMed Web of Science ®Google Scholar
• Bihlet AR, Byrjalsen I, Bay-Jensen AC, et al. Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis. Arthritis Res Ther. 2019;21(1):1–10.
   PubMed Web of Science ®Google Scholar
• Bin Cheng H, Hao B, Sun J, et al. C-terminal cross-linked telopeptides of type II collagen as biomarker for radiological knee osteoarthritis: a meta-analysis. Cartilage. 2020;11(4):512–520.
   PubMed Web of Science ®Google Scholar
• Gjaltema RAF, Bank RA. Molecular insights into prolyl and lysyl hydroxylation of fibrillar collagens in health and disease. Crit Rev Biochem Mol Biol. 2017;52(1):74–95.
   PubMed Web of Science ®Google Scholar
• Amudeswari S, Liang JN, Chakrabarti B. Polar-apolar characteristics and fibrillogenesis of glycosylated collagen. Collagen Relat Res. 1987;7(3):215–223.
   PubMedGoogle Scholar
• Bätge B, Winter C, Notbohm H, et al. Glycosylation of human bone collagen I in relation to lysylhydroxylation and fibril diameter. J Biochem. 1997;122(1):109–115.
   PubMed Web of Science ®Google Scholar
• Notbohm H, Nokelainen M, Myllyharju J, et al. Recombinant human type II collagens with low and high levels of hydroxylysine and its glycosylated forms show marked differences in fibrillogenesis in vitro. J Biol Chem. 1999;274(13):8988–8992.
   PubMed Web of Science ®Google Scholar
• Terajima M, Perdivara I, Sricholpech M, et al. Glycosylation and cross-linking in bone type I collagen. J Biol Chem. 2014;289(33):22636–22647.
   PubMed Web of Science ®Google Scholar
• Sricholpech M, Perdivara I, Yokoyama M, et al. Lysyl hydroxylase 3-mediated glucosylation in type I collagen: molecular loci and biological significance. J Biol Chem. 2012;287(27):22998–23009.
   PubMed Web of Science ®Google Scholar
• Schegg B, Hülsmeier AJ, Rutschmann C, et al. Core glycosylation of collagen is initiated by two β(1-O)Galactosyltransferases. Mol Cell Biol. 2009;29(4):943–952.
   PubMed Web of Science ®Google Scholar
• Kar K, Ibrar S, Nanda V, et al. Aromatic interactions promote self-association of collagen triple-helical peptides to higher-order structures. Biochemistry. 2009;48(33):7959–7968.
   PubMed Web of Science ®Google Scholar
• Kar K, Amin P, Bryan MA, et al. Self-association of collagen triple helic peptides into higher order structures. J Biol Chem. 2006;281(44):33283–33290.
   PubMed Web of Science ®Google Scholar
• Doege KJ, Fessler JH. Folding of carboxyl domain and assembly of procollagen I. J Biol Chem. 1986;261(19):8924–8935. http://www.ncbi.nlm.nih.gov/pubmed/3722183
   PubMed Web of Science ®Google Scholar
• Bächinger HP, Bruckner P, Timpl R, et al. Folding mechanism of the triple helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond isomerization. Eur J Biochem. 1980;106(2):619–632.
   PubMedGoogle Scholar
• Lees JF, Bulleid NJ. The role of cysteine residues in the folding and association of the COOH- terminal propeptide of types I and III procollagen. J Biol Chem. 1994;269(39):24354–24360.
   PubMed Web of Science ®Google Scholar
• DiChiara AS, Li RC, Suen PH, et al. A cysteine-based molecular code informs collagen C-propeptide assembly. Nat Commun. 2018;9(1):4206.
   PubMed Web of Science ®Google Scholar
• Pace JM, Kuslich CD, Willing MC, et al. Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfec. J Med Genet. 2001;38(7):443–449.
   PubMed Web of Science ®Google Scholar
• Siebold B, Deutzmann R, Kühn K. The arrangement of intra- and intermolecular disulfide bonds in the carboxyterminal, non-collagenous aggregation and cross-linking domain of basement-membrane type IV collagen. Eur J Biochem. 1988;176(3):617–624.
   PubMedGoogle Scholar
• Duncan KG, Fessler LI, Bächinger HP, et al. Procollagen IV. Association to tetramers. J Biol Chem. 1983;258(9):5869–5877. http://www.ncbi.nlm.nih.gov/pubmed/6853554
   PubMed Web of Science ®Google Scholar
• Hudson DM, Archer M, King KB, et al. Glycation of type I collagen selectively targets the same helical domain lysine sites as lysyl oxidase-mediated cross-linking. J Biol Chem. 2018;293(40):15620–15627.
   PubMed Web of Science ®Google Scholar
• Gautieri A, Redaelli A, Buehler MJ, et al. Age- and diabetes-related nonenzymatic crosslinks in collagen fibrils: candidate amino acids involved in Advanced Glycation End-products. Matrix Biol. 2014;34:89–95.
   PubMed Web of Science ®Google Scholar
• Collier TA, Nash A, Birch HL, et al. Effect on the mechanical properties of type I collagen of intra-molecular lysine-arginine derived advanced glycation end-product cross-linking. J Biomech. 2018;67:55–61.
   PubMed Web of Science ®Google Scholar
• Verzijl N, DeGroot J. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage. Arthritis Rheumatism. 2002;46:114–123.
   PubMed Web of Science ®Google Scholar
• Chen A, Temple M, Ng D, et al. Age-related crosslinking alters tensile properties of articular cartilage. Orthop Res Soc. 2001;26:0128.
   Google Scholar
• Hausmann E. Cofactor requirements for the enzymatic hydroxylation of lysine in a polypeptide precursor of collagen. Biochim Biophys Acta. 1967;133(3):591–593.
   PubMed Web of Science ®Google Scholar
• Hautala T, Byers MG, Eddy RL, et al. Cloning of human lysyl hydroxylase: complete cDNA-derived amino acid sequence and assignment of the gene (PLOD) to chromosome 1p36.3→p36.2. Genomics. 1992;13(1):62–69.
   PubMed Web of Science ®Google Scholar
• Takaluoma K, Lantto J, Myllyharju J. Lysyl hydroxylase 2 is a specific telopeptide hydroxylase, while all three isoenzymes hydroxylate collagenous sequences. Matrix Biol. 2007;26(5):396–403.
   PubMed Web of Science ®Google Scholar
• Kellokumpu S, Sormunen R, Heikkinen J, et al. Lysyl hydroxylase, a collagen processing enzyme, exemplifies a novel class of luminally-oriented peripheral membrane proteins in the endoplasmic reticulum. J Biol Chem. 1994;269(48):30524–30529.
   PubMed Web of Science ®Google Scholar
• Suokas M, Lampela O, Juffer AH, et al. Retrieval-independent localization of lysyl hydroxylase in the endoplasmic reticulum via a peptide fold in its iron-binding domain. Biochem J. 2003;370(3):913–920.
   PubMed Web of Science ®Google Scholar
• Boudko SP, Ishikawa Y, Lerch TF, et al. Crystal structures of wild-type and mutated cyclophilin B that causes hyperelastosis cutis in the American quarter horse. BMC Res Notes. 2012;5(1):626.
   PubMedGoogle Scholar
• Ishikawa Y, Vranka JA, Boudko SP, et al. Mutation in cyclophilin B that causes hyperelastosis cutis in american quarter horse does not affect peptidylprolyl cis-trans isomerase activity but shows altered cyclophilin b-protein interactions and affects collagen folding. J Biol Chem. 2012;287(26):22253–22265.
   PubMed Web of Science ®Google Scholar
• Heard ME, Besio R, Weis MA, et al. Sc65-null mice provide evidence for a novel endoplasmic reticulum complex regulating collagen lysyl hydroxylation. PLoS Genet. 2016;12(4):1–24.
   Web of Science ®Google Scholar
• Gjaltema RAF, van der Stoel MM, Boersema M, et al. Disentangling mechanisms involved in collagen pyridinoline cross-linking: the immunophilin FKBP65 is critical for dimerization of lysyl hydroxylase 2. Proc Natl Acad Sci U S A. 2016;113(26):7142–7147.
   PubMed Web of Science ®Google Scholar
• Duran I, Martin JH, Weis MA, et al. A chaperone complex formed by HSP47, FKBP65, and BiP modulates telopeptide lysyl hydroxylation of type I procollagen. J Bone Miner Res. 2017;32(6):1309–1319.
   PubMed Web of Science ®Google Scholar
• Chen Y, Guo H, Terajima M, et al. Lysyl hydroxylase 2 is secreted by tumor cells and can modify collagen in the extracellular space. J Biol Chem. 2016;291(50):25799–25808.
   PubMed Web of Science ®Google Scholar
• Salo AM, Wang C, Sipilä L, et al. Lysyl hydroxylase 3 (LH3) modifies proteins in the extracellular space, a novel mechanism for matrix remodeling. J Cell Physiol. 2006;207:644–653.
   PubMed Web of Science ®Google Scholar
• Wang C, Ristiluoma MM, Salo AM, et al. Lysyl hydroxylase 3 is secreted from cells by two pathways. J Cell Physiol. 2012;227(2):668–675.
   PubMed Web of Science ®Google Scholar
• Wang C, Kovanen V, Raudasoja P, et al. The glycosyltransferase activities of lysyl hydroxylase 3 (LH3) in the extracellular space are important for cell growth and viability. J Cell Mol Med. 2009;13:508–521.
   PubMed Web of Science ®Google Scholar
• Kivirikko KI, Ryhänen L, Anttinen H, et al. Further hydroxylation of lysyl residues in collagen by protocollagen lysyl hydroxylase in vitro. Biochemistry. 1973;12(24):4966–4971.
   PubMed Web of Science ®Google Scholar
• Puistola U, Turpeenniemi-Hujanen TM, Myllylä R, et al. Studies on the lysyl hydr oxylase reaction. II. Inhibition kinetics and the reaction mechanism. Biochim Biophys Acta. 1980;611(1):51–60.
   PubMed Web of Science ®Google Scholar
• Zdzisińska B, Żurek A, Kandefer-Szerszeń M. Alpha-Ketoglutarate as a molecule with pleiotropic activity: well-known and novel possibilities of therapeutic use. Arch Immunol Ther Exp (Warsz). 2017;65(1):21–36.
   PubMed Web of Science ®Google Scholar
• Martin M, Ferrier B, Baverel G. Transport and utilization of alpha-ketoglutarate by the rat kidney in vivo. Pflugers Arch. 1989;413(3):217–224.
   PubMed Web of Science ®Google Scholar
• Wagner BM, Donnarumma F, Wintersteiger R, et al. Simultaneous quantitative determination of alpha-ketoglutaric acid and 5-hydroxymethylfurfural in human plasma by gas chromatography-mass spectrometry. Anal Bioanal Chem. 2010;396(7):2629–2637.
   PubMed Web of Science ®Google Scholar
• Otto C, Yovkova V, Barth G. Overproduction and secretion of α-ketoglutaric acid by microorganisms. Appl Microbiol Biotechnol. 2011;92(4):689–695.
   PubMed Web of Science ®Google Scholar
• Ruotsalainen H, Sipilä L, Vapola M, et al. Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes. J Cell Sci. 2006;119(4):625–635.
   PubMed Web of Science ®Google Scholar
• Rautavuoma K, Takaluoma K, Sormunen R, et al. Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice. Proc Natl Acad Sci U S A. 2004;101(39):14120–14125.
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Risteli M, Wang C, et al. Lysyl hydroxylase 3 is a multifunctional protein possessing collagen glucosyltransferase activity. J Biol Chem. 2000;275(46):36158–36163.
   PubMed Web of Science ®Google Scholar
• Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol. 2001;70:1–32.
   PubMed Web of Science ®Google Scholar
• Maruhashi T, Kii I, Saito M, et al. Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. J Biol Chem. 2010;285(17):13294–13303.
   PubMed Web of Science ®Google Scholar
• Kalamajski S, Bihan D, Bonna A, et al. Fibromodulin interacts with collagen cross-linking sites and activates lysyl oxidase. J Biol Chem. 2016;291(15):7951–7960.
   PubMed Web of Science ®Google Scholar
• Kadler KE, Hill A, Canty-Laird EG. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol. 2008;20(5):495–501.
   PubMed Web of Science ®Google Scholar
• Zhao B, Zhou J. Decreased expression of elastin, fibulin-5 and lysyl oxidase-like 1 in the uterosacral ligaments of postmenopausal women with pelvic organ prolapse. J Obstet Gynaecol Res. 2012;38(6):925–931.
   PubMed Web of Science ®Google Scholar
• Fogelgren B, Polgár N, Szauter KM, et al. Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J Biol Chem. 2005;280(26):24690–24697.
   PubMed Web of Science ®Google Scholar
• López-Jiménez AJ, Basak T, Vanacore RM. Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV. J Biol Chem. 2017;292(41):16970–16982.
   PubMed Web of Science ®Google Scholar
• Atsawasuwan P, Mochida Y, Katafuchi M, et al. A novel proteolytic processing of prolysyl oxidase. Connect Tissue Res. 2011;52(6):479–486.
   PubMed Web of Science ®Google Scholar
• Uzel MI, Scott IC, Babakhanlou-Chase H, et al. Multiple bone morphogenetic protein 1-related Mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures. J Biol Chem. 2001;276(25):22537–22543.
   PubMed Web of Science ®Google Scholar
• Okada K, Moon HJ, Finney J, et al. Extracellular processing of lysyl oxidase-like 2 and its effect on amine oxidase activity. Biochemistry. 2018;57(51):6973–6983.
   PubMed Web of Science ®Google Scholar
• Kessler E, Takahara K, Biniaminov L, et al. Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science. 1996;271(5247):360–362.
   PubMed Web of Science ®Google Scholar
• Kessler E, Fichard A, Chanut-Delalande H, et al. Bone morphogenetic protein-1 (BMP-1) mediates C-terminal processing of procollagen V homotrimer. J Biol Chem. 2001;276(29):27051–27057.
   PubMed Web of Science ®Google Scholar
• Davidson VL. 7.19 - protein-derived cofactors. (Ben) Liu H-W, Mander LBT-CNPII, editors Compr. Nat. Prod. II. Elsevier: Oxford. 2010. 686–687. DOI:https://doi.org/10.1016/B978-008045382-8.00143-X
   Google Scholar
• Lucero HA, Kagan HM. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci. 2006;63(19–20):2304–2316.
   PubMed Web of Science ®Google Scholar
• Bains W. Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age. Rejuvenation Res. 2013;16(6):495–517.
   PubMed Web of Science ®Google Scholar
• Chau DYS, Collighan RJ, Verderio EAM, et al. The cellular response to transglutaminase-cross-linked collagen. Biomaterials. 2005;26(33):6518–6529.
   PubMed Web of Science ®Google Scholar
• Tatsukawa H, Tani Y, Otsu R, et al. Global identification and analysis of isozyme-specific possible substrates crosslinked by transglutaminases using substrate peptides in mouse liver fibrosis. Sci Rep. 2017;7(1):45049.
   PubMed Web of Science ®Google Scholar
• Kleman JP, Aeschlimann D, Paulsson M, et al. Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 Rhabdomyosarcoma cells. Biochemistry. 1995;34(42):13768–13775.
   PubMed Web of Science ®Google Scholar
• Bowness JM, Folk JE, Timpl R. Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen. J Biol Chem. 1987;262(3):1022–1024.
   PubMed Web of Science ®Google Scholar
• Siegel M, Strnad P, Watts RE, et al. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One. 2008;3(3):e1861.
   PubMed Web of Science ®Google Scholar
• Akimov SS, Krylov D, Fleischman LF, et al. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol. 2000;148:825–838.
   PubMed Web of Science ®Google Scholar
• Telci D, Wang Z, Li X, et al. Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem. 2008;283:20937–20947.
   PubMed Web of Science ®Google Scholar
• Stamnaes J, Cardoso I, Iversen R, et al. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain. FEBS J. 2016;283(21):3994–4010.
   PubMed Web of Science ®Google Scholar
• Király R, Demény M, Fésüs L. Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+-dependent action of a multifunctional protein. FEBS J. 2011;278(24):4717–4739.
   PubMed Web of Science ®Google Scholar
• Stamnaes J, Pinkas DM, Fleckenstein B, et al. Redox regulation of transglutaminase 2 activity. J Biol Chem. 2010;285(33):25402–25409.
   PubMed Web of Science ®Google Scholar
• Jin X, Stamnaes J, Klöck C, et al. Activation of extracellular transglutaminase 2 by thioredoxin. J Biol Chem. 2011;286(43):37866–37873.
   PubMed Web of Science ®Google Scholar
• Santhanam L, Tuday EC, Webb AK, et al. Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness. Circ Res. 2010;107:117–125.
   PubMed Web of Science ®Google Scholar
• Lai TS, Hausladen A, Slaughter TF, et al. Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry. 2001;40(16):4904–4910.
   PubMed Web of Science ®Google Scholar
• Huelsz-Prince G, Belkin AM, VanBavel E, et al. Activation of extracellular transglutaminase 2 by mechanical force in the arterial wall. J Vasc Res. 2013;50(5):383–395.
   PubMed Web of Science ®Google Scholar
• Pinkas DM, Strop P, Brunger AT, et al. Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol. 2007;5(12):e327.
   PubMed Web of Science ®Google Scholar
• Keillor JW, Clouthier CM, Apperley KYP, et al. Acyl transfer mechanisms of tissue transglutaminase. Bioorg Chem. 2014;57:186–197.
   PubMed Web of Science ®Google Scholar
• Stamnaes J, Fleckenstein B, Sollid LM. The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim Biophys Acta. 2008;1784(11):1804–1811.
   PubMed Web of Science ®Google Scholar
• Bhave G, Colon S, Ferrell N. The sulfilimine cross-link of collagen IV contributes to kidney tubular basement membrane stiffness. Am J Physiol Renal Physiol. 2017;313(3):F596–F602.
   PubMed Web of Science ®Google Scholar
• Vanacore RM, Friedman DB, Ham AJL, et al. Identification of S-hydroxylysyl-methionine as the covalent cross-link of the noncollagenous (NC1) hexamer of the α1α1α2 collagen IV network: a role for the post-translational modification of lysine 211 to hydroxylysine 211 in hexamer assembly. J Biol Chem. 2005;280(32):29300–29310.
   PubMed Web of Science ®Google Scholar
• Davies MJ, Hawkins CL, Pattison DI, et al. Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008;10(7):1199–1234.
   PubMed Web of Science ®Google Scholar
• Furtmüller PG, Zederbauer M, Jantschko W, et al. Active site structure and catalytic mechanisms of human peroxidases. Arch Biochem Biophys. 2006;445:199–213.
   PubMed Web of Science ®Google Scholar
• Ero-Tolliver IA, Hudson BG, Bhave G. The ancient immunoglobulin domains of peroxidasin are required to form sulfilimine cross-links in collagen IV. J Biol Chem. 2015;290(35):21741–21748.
   PubMed Web of Science ®Google Scholar
• Bhave G, Cummings CF, Vanacore RM, et al. Peroxidasin forms sulfilimine chemical bonds using hypohalous acids in tissue genesis. Nat Chem Biol. 2012;8(9):784–790.
   PubMed Web of Science ®Google Scholar
• McCall AS, Cummings CF, Bhave G, et al. Bromine is an essential trace element for assembly of collagen IV scaffolds in tissue development and architecture. Cell. 2014;157(6):1380–1392.
   PubMed Web of Science ®Google Scholar
• Ronsein GE, Winterbourn CC, Di Mascio P, et al. Cross-linking methionine and amine residues with reactive halogen species. Free Radic Biol Med. 2014;70:278–287.
   PubMed Web of Science ®Google Scholar
• Sirokmány G, Kovács HA, Lázár E, et al. Peroxidasin-mediated crosslinking of collagen IV is independent of NADPH oxidases. Redox Biol. 2018;16:314–321.
   PubMed Web of Science ®Google Scholar
• Sirokmány G, Geiszt M. The relationship of NADPH oxidases and heme peroxidases: fallin’ in and out. Front Immunol. 2019;10:1–8.
   PubMed Web of Science ®Google Scholar
• Rees MD, McNiven TN, Davies MJ. Degradation of extracellular matrix and its components by hypobromous acid. Biochem J. 2007;401(2):587–596.
   PubMed Web of Science ®Google Scholar
• Rees MD, Kennett EC, Whitelock JM, et al. Oxidative damage to extracellular matrix and its role in human pathologies. Free Radic Biol Med. 2008;44:1973–2001.
   PubMed Web of Science ®Google Scholar
• Bathish B, Paumann-Page M, Paton LN, et al. Peroxidasin mediates bromination of tyrosine residues in the extracellular matrix. J Biol Chem. 2020;295:12697–12705.
   PubMed Web of Science ®Google Scholar
• Paumann-Page M, Tscheliessnig R, Sevcnikar B, et al. Monomeric and homotrimeric solution structures of truncated human peroxidasin 1 variants. Biochim Biophys Acta Proteins Proteomics. 2020;1868(1):140249.
   PubMed Web of Science ®Google Scholar
• Sevcnikar B, Schaffner I, Chuang CY, et al. The leucine-rich repeat domain of human peroxidasin 1 promotes binding to laminin in basement membranes. Arch Biochem Biophys. 2020;689:108443.
   PubMed Web of Science ®Google Scholar
• Nagaraju CK, Robinson EL, Abdesselem M, et al. Myofibroblast phenotype and reversibility of fibrosis in patients with end-stage heart failure. J Am Coll Cardiol. 2019;73:2267–2282.
   PubMed Web of Science ®Google Scholar
• Westergren-Thorsson G, Hernnäs J, Särnstrand B, et al. Altered expression of small proteoglycans, collagen, and transforming growth factor-β1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest. 1993;92(2):632–637.
   PubMed Web of Science ®Google Scholar
• Alexakis C, Caruelle JP, Sezeur A, et al. Reversal of abnormal collagen production in Crohn’s disease intestinal biopsies treated with regenerating agents. Gut. 2004;53:85–90.
   PubMed Web of Science ®Google Scholar
• Veidal SS, Karsdal MA, Nawrocki A, et al. Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis. Fibrogenesis Tissue Repair. 2011;4(1):22.
   PubMedGoogle Scholar
• Santos A, Lagares D. Matrix stiffness: the conductor of organ fibrosis. Curr Rheumatol Rep. 2018;20(1):2.
   PubMed Web of Science ®Google Scholar
• Klingberg F, Hinz B, White ES. The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol. 2013;229(2):298–309.
   PubMed Web of Science ®Google Scholar
• Piersma B, Bank RA. Collagen cross-linking mediated by lysyl hydroxylase 2: an enzymatic battlefield to combat fibrosis. Essays Biochem. 2019;63(3):377–387.
   PubMed Web of Science ®Google Scholar
• Van Der Slot AJ, Zuurmond AM, Van Den Bogaerdt AJ, et al. Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon. Matrix Biol. 2004;23(4):251–257.
   PubMed Web of Science ®Google Scholar
• Van Der Slot AJ, Zuurmond A-M-M, Bardoel AFJJ, et al. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem. 2003;278(42):40967–40972.
   PubMed Web of Science ®Google Scholar
• Remst DFG, Blaney Davidson EN, Vitters EL, et al. Osteoarthritis-related fibrosis is associated with both elevated pyridinoline cross-link formation and lysyl hydroxylase 2b expression. Osteoarthr Cartil. 2013;21(1):157–164.
   PubMed Web of Science ®Google Scholar
• Shao S, Fang H, Duan L, et al. Lysyl hydroxylase 3 increases collagen deposition and promotes pulmonary fibrosis by activating TGFβ1/Smad3 and Wnt/β-catenin pathways. Arch Med Sci. 2020;16(2):436–445.
   PubMed Web of Science ®Google Scholar
• Brinckmann J, Kim S, Wu J, et al. Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma? Matrix Biol. 2005;24(7):459–468.
   PubMed Web of Science ®Google Scholar
• López B, González A, Hermida N, et al. Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects. Am J Physiol Heart Circ Physiol. 2010;299(1):H1–9.
   PubMed Web of Science ®Google Scholar
• Chen L, Li S, Li W. LOX/LOXL in pulmonary fibrosis: potential therapeutic targets. J Drug Target. 2019;27(7):790–796.
   PubMed Web of Science ®Google Scholar
• Benn MC, Weber W, Klotzsch E, et al. Tissue transglutaminase in fibrosis — more than an extracellular matrix cross-linker. Curr Opin Biomed Eng. 2019;10:156–164.
   Google Scholar
• Kyung SY, Byun KH, Yoon JY, et al. Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP. Int J Clin Exp Pathol. 2014;7:221–228. http://www.ncbi.nlm.nih.gov/pubmed/24427342
   PubMed Web of Science ®Google Scholar
• Hägglund P, Mariotti M, Davies MJ. Identification and characterization of protein cross-links induced by oxidative reactions. Expert Rev Proteomics. 2018;15(8):665–681.
   PubMed Web of Science ®Google Scholar
• Marenzana M, Wilson-Jones N, Mudera V, et al. The origins and regulation of tissue tension: identification of collagen tension-fixation process in vitro. Exp Cell Res. 2006;312(4):423–433.
   PubMed Web of Science ®Google Scholar
• Grinnell F, Petroll WM. Cell motility and mechanics in three-dimensional collagen matrices. Annu Rev Cell Dev Biol. 2010;26:335–361.
   PubMed Web of Science ®Google Scholar
• Lin Y-C, Sung YK, Jiang X, et al. Simultaneously targeting myofibroblast contractility and extracellular matrix cross-linking as a therapeutic concept in airway fibrosis. Am J Transplant. 2017;17(5):1229–1241.
   PubMed Web of Science ®Google Scholar
• Liu SB, Ikenaga N, Peng ZW, et al. Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice. FASEB J. 2016;30(4):1599–1609.
   PubMed Web of Science ®Google Scholar
• Robins SP, Milne G, Duncan A, et al. Increased skin collagen extractability and proportions of collagen type III are not normalized after 6 months healing of human excisional wounds. J Invest Dermatol. 2003;121(2):267–272.
   PubMed Web of Science ®Google Scholar
• van den Bos T, Speijer D, Bank RA, et al. Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption. Special emphasis on collagen. Bone. 2008;43(2):459–468.
   PubMed Web of Science ®Google Scholar
• van der Slot-Verhoeven AJ, van Dura EA, Attema J, et al. The type of collagen cross-link determines the reversibility of experimental skin fibrosis. Biochim Biophys Acta. 2005;1740:60–67.
   PubMed Web of Science ®Google Scholar
• Philp CJ, Siebeke I, Clements D, et al. Extracellular matrix cross-linking enhances fibroblast growth and protects against matrix proteolysis in lung fibrosis. Am J Respir Cell Mol Biol. 2018;58(5):594–603.
   PubMed Web of Science ®Google Scholar
• Wang Z, Stuckey DJ, Murdoch CE, et al. Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. Cell Death Dis. 2018;9(6):613.
   PubMed Web of Science ®Google Scholar
• Olsen KC, Epa AP, Kulkarni AA, et al. Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules. Am J Respir Cell Mol Biol. 2014;50(4):737–747.
   PubMed Web of Science ®Google Scholar
• Popov Y, Sverdlov DY, Sharma AK, et al. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice. Gastroenterology. 2011;140(5):1642–1652.
   PubMed Web of Science ®Google Scholar
• Klingberg F, Chau G, Walraven M, et al. The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix. J Cell Sci. 2018;131. DOI:https://doi.org/10.1242/jcs.201293.
   Google Scholar
• Nunes I, Gleizes PE, Metz CN, et al. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol. 1997;136:1151–1163.
   PubMed Web of Science ®Google Scholar
• Hinz B, McCulloch CA, Coelho NM. Mechanical regulation of myofibroblast phenoconversion and collagen contraction. Exp Cell Res. 2019;379(1):119–128.
   PubMed Web of Science ®Google Scholar
• Klingberg F, Chow ML, Koehler A, et al. Prestress in the extracellular matrix sensitizes latent TGF-β1 for activation. J Cell Biol. 2014;207(2):283–297.
   PubMed Web of Science ®Google Scholar
• Zheng YZ, Liang L. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer. Ann Diagn Pathol. 2018;34:161–165.
   PubMed Web of Science ®Google Scholar
• Colon S, Luan H, Liu Y, et al. Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model. Am J Physiol Physiol. 2019;316(2):F360–F371.
   PubMed Web of Science ®Google Scholar
• Johnson LA, Rodansky ES, Sauder KL, et al. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts. Inflamm Bowel Dis. 2013;19(5):891–903.
   PubMed Web of Science ®Google Scholar
• Tschumperlin DJ, Ligresti G, Hilscher MB, et al. Mechanosensing and fibrosis. J Clin Invest. 2018;128(1):74–85.
   PubMed Web of Science ®Google Scholar
• Ciobanasu C, Faivre B, Le Clainche C. Integrating actin dynamics, mechanotransduction and integrin activation: the multiple functions of actin binding proteins in focal adhesions. Eur J Cell Biol. 2013;92(10–11):339–348.
   PubMed Web of Science ®Google Scholar
• Schiller HB, Fässler R. Mechanosensitivity and compositional dynamics of cell-matrix adhesions. EMBO Rep. 2013;14(6):509–519.
   PubMed Web of Science ®Google Scholar
• Solon J, Levental I, Sengupta K, et al. Fibroblast adaptation and stiffness matching to soft elastic substrates. Biophys J. 2007;93(12):4453–4461.
   PubMed Web of Science ®Google Scholar
• Huang X, Yang N, Fiore VF, et al. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am J Respir Cell Mol Biol. 2012;47(3):340–348.
   PubMed Web of Science ®Google Scholar
• Dupont S, Morsut L, Aragona M, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474(7350):179–183.
   PubMed Web of Science ®Google Scholar
• Iyer KV, Pulford S, Mogilner A, et al. Mechanical activation of cells induces chromatin remodeling preceding MKL nuclear transport. Biophys J. 2012;103(7):1416–1428.
   PubMed Web of Science ®Google Scholar
• Liu F, Lagares D, Choi KM, et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2015;308(4):L344–57.
   PubMed Web of Science ®Google Scholar
• Cockerill M, Rigozzi MK, Terentjev EM. Mechanosensitivity of the 2nd kind: TGF-β mechanism of cell sensing the substrate stiffness. PLoS One. 2015;10(10):e0139959.
   PubMed Web of Science ®Google Scholar
• Munger JS, Sheppard D. Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb Perspect Biol. 2011;3(11):a005017.
   PubMed Web of Science ®Google Scholar
• Sethi A, Mao W, Wordinger RJ, et al. Transforming growth factor–β induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2011;52(8):5240–5250.
   PubMed Web of Science ®Google Scholar
• Roy R, Polgar P, Wang Y, et al. Regulation of lysyl oxidase and cyclooxygenase expression in human lung fibroblasts: interactions among TGF-beta, IL-1 beta, and prostaglandin E. J Cell Biochem. 1996;62(3):411–417.
   PubMed Web of Science ®Google Scholar
• Telci D, Collighan RJ, Basaga H, et al. Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide. J Biol Chem. 2009;284:29547–29558.
   PubMed Web of Science ®Google Scholar
• Meng X-M, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325–338.
   PubMed Web of Science ®Google Scholar
• Hünerwadel A, Fagagnini S, Rogler G, et al. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis. Sci Rep. 2018;8(1):1–13.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–2082.
   PubMed Web of Science ®Google Scholar
• Noble PW, Albera C, Bradford WZ, et al. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Eur Respir J. 2016;47(1):243–253.
   PubMed Web of Science ®Google Scholar
• Horowitz JC, Thannickal VJ. Mechanisms for the resolution of organ fibrosis. Physiology. 2018;34:43–55.
   Web of Science ®Google Scholar
• Bellaye P-S, Shimbori C, Upagupta C, et al. Lysyl oxidase-like 1 protein deficiency protects mice from adenoviral transforming growth factor-β1-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2018;58:461–470.
   PubMed Web of Science ®Google Scholar
• Harlow CR, Wu X, Van Deemter M, et al. Targeting lysyl oxidase reduces peritoneal fibrosis. PLoS One. 2017;12(8):e0183013.
   PubMed Web of Science ®Google Scholar
• Martínez-Martínez E, Rodríguez C, Galán M, et al. The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats. J Mol Cell Cardiol. 2016;92:96–104.
   PubMed Web of Science ®Google Scholar
• Murad S, Walker LC, Tajima S, et al. Minimum structural requirements for minoxidil inhibition of lysyl hydroxylase in cultured fibroblasts. Arch Biochem Biophys. 1994;308(1):42–47.
   PubMed Web of Science ®Google Scholar
• Shao S, Zhang X, Duan L, et al. Lysyl hydroxylase inhibition by minoxidil blocks collagen deposition and prevents pulmonary fibrosis via TGF-β₁/Smad3 signaling pathway. Med Sci Monit. 2018;24:8592–8601.
   PubMed Web of Science ®Google Scholar
• Leiva O, Ng SK, Matsuura S, et al. Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice. Int J Hematol. 2019;110(6):699–708.
   PubMed Web of Science ®Google Scholar
• Mahjour F, Dambal V, Shrestha N, et al. Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB. Oncogenesis. 2019;8(5):34.
   PubMed Web of Science ®Google Scholar
• Muir AJ, Levy C, Janssen HLA, et al. GS-US-321-0102 investigators, simtuzumab for primary sclerosing cholangitis: phase 2 study results with insights on the natural history of the disease. Hepatology. 2019;69(2):684–698.
   PubMed Web of Science ®Google Scholar
• Harrison SA, Abdelmalek MF, Caldwell S, et al. GS-US-321-0105 and GS-US-321-0106 investigators, simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis. Gastroenterology. 2018;155(4):1140–1153.
   PubMed Web of Science ®Google Scholar
• Schilter H, Findlay AD, Perryman L, et al. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. J Cell Mol Med. 2019;23(3):1759–1770.
   PubMed Web of Science ®Google Scholar
• Puente A, Fortea JI, Cabezas J, et al. LOXL2—A new target in antifibrogenic therapy? Int J Mol Sci. 2019;20(7):1–12.
   Web of Science ®Google Scholar
• Smithen DA, Leung LMH, Challinor M, et al. 2-aminomethylene-5-sulfonylthiazole inhibitors of lysyl oxidase (LOX) and LOXL2 show significant efficacy in delaying tumor growth. J Med Chem. 2020;63(5):2308–2324.
   PubMed Web of Science ®Google Scholar
• Holvoet T, Devriese S, Castermans K, et al. Treatment of Intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local Rho kinase inhibitor. Gastroenterology. 2017;153(4):1054–1067.
   PubMed Web of Science ®Google Scholar
• Tschumperlin DJ, Lagares D. Mechano-therapeutics: targeting mechanical signaling in fibrosis and tumor stroma. Pharmacol Ther. 2020;212:107575.
   PubMed Web of Science ®Google Scholar
• Ratziu V, Charlotte F, Heurtier A, et al. LIDO study group, sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128(7):1898–1906.
   PubMed Web of Science ®Google Scholar
• Laursen TL, Villesen IF, Leeming DJ, et al. Altered balance between collagen formation and degradation after successful direct-acting antiviral therapy of chronic hepatitis C. J Viral Hepat. 2021;28(2):236–244.
   PubMed Web of Science ®Google Scholar
• Kubo S, Siebuhr AS, Bay-Jensen A-C, et al. Correlation between serol ogical biomarkers of extracellular matrix turnover and lung fibrosis and pulm onary artery hyper tension in patients with systemic sclerosis. Int J Rheum Dis. 2020;23(4):532–539.
   PubMed Web of Science ®Google Scholar
• Genovese F, Rasmussen DGK, Karsdal MA, et al. Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients. Clin Kidney J. 2020;1–9. DOI:https://doi.org/10.1093/ckj/sfz174
   Google Scholar
• Mortensen JH, Lindholm M, Langholm LL, et al. The intestinal tissue homeostasis - the role of extracellular matrix remodeling in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2019;13(10):977–993.
   PubMed Web of Science ®Google Scholar
• Organ LA, Duggan A-MR, Oballa E, et al. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort. Respir Res. 2019;20(1):148.
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Daniels SJ, Holm Nielsen S, et al. Collagen biology and non-invasive biomarkers of liver fibrosis. Liver Int. 2020;1–15. DOI:https://doi.org/10.1111/liv.14390
   Google Scholar
• Sharma S, Khalili K, Nguyen GC. Non-invasive diagnosis of advanced fibrosis and cirrhosis. World J Gastroenterol. 2014;20(45):16820–16830.
   PubMed Web of Science ®Google Scholar
• Giuffrida P, Pinzani M, Corazza GR, et al. Biomarkers of intestinal fibrosis – one step towards clinical trials for stricturing inflammatory bowel disease. United Eur Gastroenterol J. 2016;4(4):523–530.
   PubMed Web of Science ®Google Scholar
• Giann andrea M, Parks WC. Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech. 2014;7(2):193–203.
   PubMed Web of Science ®Google Scholar
• Ravassa S, Trippel T, Bach D, et al. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial. Eur J Heart Fail. 2018;20(9):1290–1299.
   PubMed Web of Science ®Google Scholar
• Leeming DJ, Willumsen N, Sand JMB, et al. A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis. Biochem Biophys Rep. 2019;17:38–43.
   PubMedGoogle Scholar
• Devkota AK, Veloria JR, Guo H-F, et al. Development of a high-throughput Lysyl Hydroxylase (LH) assay and identification of small-molecule inhibitors against LH2. SLAS Discov Adv Life Sci R D. 2019;24:484–491.
   PubMed Web of Science ®Google Scholar